Benign paroxysmal positional vertigo differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 29: | Line 29: | ||
|- style="background: #4479BA; color: #FFFFFF; text-align: center;" | |- style="background: #4479BA; color: #FFFFFF; text-align: center;" | ||
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ||
| colspan=" | | colspan="7" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations''' | ||
! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings | ! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings | ||
| colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard''' | | colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard''' | ||
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ||
|- | |- | ||
| colspan=" | | colspan="4" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Symptoms''' | ||
! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination | ! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination | ||
|- | |- | ||
Line 41: | Line 41: | ||
|- | |- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acute onset | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acute onset | ||
!Recurrency | |||
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Nystagmus | ! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Nystagmus | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hearing problems | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hearing problems | ||
Line 50: | Line 51: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI | ||
|- | |- | ||
| colspan=" | | colspan="13" style="background: #7d7d7d; color: #FFFFFF; text-align: center;" |'''Peripheral''' | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |BPPV | | style="background: #DCDCDC; padding: 5px; text-align: center;" |BPPV | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |+ | ||
| + | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
Line 67: | Line 69: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Vestibular neuritis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Vestibular neuritis | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
Line 80: | Line 83: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |HSV oticus | | style="background: #DCDCDC; padding: 5px; text-align: center;" |HSV oticus | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
Line 93: | Line 97: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Meniere disease | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Meniere disease | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
Line 106: | Line 111: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Labyrinthine concussion | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Labyrinthine concussion | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
Line 119: | Line 125: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Perilymphatic fistula | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Perilymphatic fistula | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
Line 133: | Line 140: | ||
dehiscence syndrome | dehiscence syndrome | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
Line 146: | Line 154: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Vestibular paroxysma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Vestibular paroxysma | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
Line 159: | Line 168: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Cogan syndrome | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Cogan syndrome | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
Line 172: | Line 182: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Vestibular schwannoma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Vestibular schwannoma | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
Line 185: | Line 196: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Otitis media | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Otitis media | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
Line 198: | Line 210: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Aminoglycoside toxicity | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Aminoglycoside toxicity | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
Line 210: | Line 223: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Recurrent vestibulopathy | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Recurrent vestibulopathy | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |+ | ||
| | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
Line 222: | Line 236: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
|- style="background: #4479BA; color: #FFFFFF; text-align: center;" | |- style="background: #4479BA; color: #FFFFFF; text-align: center;" | ||
! colspan=" | ! colspan="13" style="background: #7d7d7d; color: #FFFFFF; text-align: center;" |Central | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Vestibular migrain | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Vestibular migrain | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| + | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
Line 239: | Line 254: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Epileptic vertigo | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Epileptic vertigo | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| + | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
Line 252: | Line 268: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Multiple sclerosis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Multiple sclerosis | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
Line 265: | Line 282: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Brain tumors | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Brain tumors | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
Line 277: | Line 295: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Crebellar infarction/hemorrhage | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Crebellar infarction/hemorrhage | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |+ | ||
| | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
Line 290: | Line 309: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Brain stem ischemia | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Brain stem ischemia | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |+ | ||
| | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
Line 303: | Line 323: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Chiari malformation | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Chiari malformation | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |− | ||
| | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
Line 316: | Line 337: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Parkinson | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Parkinson | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |− | ||
| | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | |
Revision as of 17:52, 15 March 2019
For the WikiDoc page for this topic, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].
OR
[Disease name] must be differentiated from [[differential dx1], [differential dx2], and [differential dx3].
Differentiating [Disease name] from other Diseases
[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].
OR
[Disease name] must be differentiated from [differential dx1], [differential dx2], and [differential dx3].
OR
As [disease name] manifests in a variety of clinical forms, differentiation must be established in accordance with the particular subtype. [Subtype name 1] must be differentiated from other diseases that cause [clinical feature 1], such as [differential dx1] and [differential dx2]. In contrast, [subtype name 2] must be differentiated from other diseases that cause [clinical feature 2], such as [differential dx3] and [differential dx4].
Differentiating [disease name] from other diseases on the basis of [symptom 1], [symptom 2], and [symptom 3]
On the basis [symptom 1], [symptom 2], and [symptom 3], [disease name] must be differentiated from [disease 1], [disease 2], [disease 3], [disease 4], [disease 5], and [disease 6].
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | |||||||||||
Lab Findings | Imaging | |||||||||||
Acute onset | Recurrency | Nystagmus | Hearing problems | Physical exam 1 | Physical exam 2 | Physical exam 3 | Lab 1 | CT scan | MRI | |||
Peripheral | ||||||||||||
BPPV | + | + | ||||||||||
Vestibular neuritis | ||||||||||||
HSV oticus | ||||||||||||
Meniere disease | ||||||||||||
Labyrinthine concussion | ||||||||||||
Perilymphatic fistula | ||||||||||||
Semicircular canal
dehiscence syndrome |
||||||||||||
Vestibular paroxysma | ||||||||||||
Cogan syndrome | ||||||||||||
Vestibular schwannoma | ||||||||||||
Otitis media | ||||||||||||
Aminoglycoside toxicity | ||||||||||||
Recurrent vestibulopathy | + | |||||||||||
Central | ||||||||||||
Vestibular migrain | + | |||||||||||
Epileptic vertigo | + | |||||||||||
Multiple sclerosis | ||||||||||||
Brain tumors | ||||||||||||
Crebellar infarction/hemorrhage | + | |||||||||||
Brain stem ischemia | + | |||||||||||
Chiari malformation | − | |||||||||||
Parkinson | − |